CHIRON VISION VITRASERT IMPLANT FOR CMV RETINITIS AVAILABLE FOLLOWING APPROVAL MARCH 4; ROCHE WILL MARKET TO PRIMARY CARE AND INFECTIOUS DISEASE MARKETS
Executive Summary
Chiron Vision is beginning immediate shipments of Vitrasert following the March 4 approval of the ganciclovir intraocular implant for cytomegalovirus retinitis treatment in people with AIDS.